increasing semaglutide from .25 to .5 White Paper: and Weight Management Is 50 units of semaglutide

Surprisingly, a growing number of clinical studies demonstrate that these drugs (and other GLP-1 RAs) may have benefits that extend far beyond their original purpose, with their effects spanning the heart, kidneys, liver, and more

However, a systematic review in 2023 found only one phase 2 randomized controlled trial of exenatide versus placebo for IIH, which did demonstrate a significant reduction in ICP at all time points, as well as improved headache and visual acuity (7,8)

All 50 patients 100% lost weight, with an average weight loss of 15.5% body weight or 43 pounds over the year

Erectile Dysfunction: AUA Guideline